Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proleukin (IL-2) with Surgery and Radiation in Oral/Oropharyngeal Cancer
NCT00002702Phase 3Unknown
- Sponsor
- European Institute of Oncology
- Start
- Sep 1992
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of aldesleukin in squamous cell carcinoma of the oral cavity (OSCC), squamous cell carcinoma of the oropharynx (OPSCC), sponsored by European Institute of Oncology. Status: unknown.
02
Drugs
aldesleukin
03
Conditions
squamous cell carcinoma of the oral cavity (OSCC)squamous cell carcinoma of the oropharynx (OPSCC)
Beyond the preview
Go deeper on NCT00002702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002702.